Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of Inhibitor Therapeutics, Inc. from Q1 2025 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
Inhibitor Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and growth rate from Q1 2025 to Q3 2025.
  • Inhibitor Therapeutics, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending September 30, 2025 was $6.99K.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)

Inhibitor Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $6.99K Sep 30, 2025 10-Q 2025-11-13
Q2 2025 $8.42K Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $9.96K Mar 31, 2025 10-Q 2025-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.